Instructions: In this task, you are given text for US Congressional and California state bills, your task is to generate a summary for this bill.
Input: SECTION 1. PARKINSON'S DISEASE RESEARCH, EDUCATION, AND CLINICAL
CENTERS.

(a) Requirement for Establishment of Centers.--
(1) In general.--Subchapter II of chapter 73 of title 38,
United States Code, is amended by adding at the end the
following new section:
''Sec. 7329. Parkinson's disease research, education, and clinical
centers
''(a) The Secretary, upon the recommendation of the Under Secretary
for Health and pursuant to the provisions of this section, shall
designate six Department health-care facilities as the locations for
centers of Parkinson's Disease research, education, and clinical
activities and (subject to the appropriation of sufficient funds for
such purpose) shall establish and operate such centers at such
locations in accordance with this section.
''(b) In designating locations for centers under subsection (a),
the Secretary, upon the recommendation of the Under Secretary for
Health, shall--
''(1) designate each Department health-care facility that
as of January 1, 2005, was operating a Parkinson's Disease
research, education, and clinical center unless (on the
recommendation of the Under Secretary for Health) the Secretary
determines that such facility does not meet the requirements of
subsection (c) or has not demonstrated effectiveness in
carrying out the established purposes of such center or the
potential to carry out such purposes effectively in the
reasonably foreseeable future; and
''(2) assure appropriate geographic distribution of such
facilities.
''(c) The Secretary may not designate a health-care facility as a
location for a center under subsection (a) unless the peer review panel
established under subsection (d) has determined under that subsection
that the proposal submitted by such facility as a location for a new
center under subsection (a) is among those proposals which have met the
highest competitive standards of scientific and clinical merit, and the
Secretary (upon the recommendation of the Under Secretary for Health)
determines that the facility has (or may reasonably be anticipated to
develop) each of the following:
''(1) An arrangement with an accredited medical school
which provides education and training in neurology and with
which such facility is affiliated under which residents receive
education and training in innovative diagnosis and treatment of
chronic neurodegenerative diseases and movement disorders,
including Parkinson's disease.
''(2) The ability to attract the participation of
scientists who are capable of ingenuity and creativity in
health-care research efforts.
''(3) A policymaking advisory committee composed of
appropriate health-care and research representatives of the
facility and of the affiliated school or schools to advise the
directors of such facility and such center on policy matters
pertaining to the activities of such center during the period
of the operation of such center.
''(4) The capability to conduct effectively evaluations of
the activities of such center.
''(5) The capability to coordinate, as part of an
integrated national system, education, clinical, and research
activities within all facilities with such centers.
''(6) The capability to jointly develop a consortium of
providers with interest in treating neurodegenerative diseases,
including Parkinson's Disease, and other movement disorders, at
facilities without such centers in order to ensure better
access to state-of-the-art diagnosis, care, and education for
neurodegenerative disorders throughout the health care system.
''(7) The capability to develop a national repository for
the collection of data on health services delivered to veterans
seeking care for neurodegenerative diseases, including
Parkinson's Disease, and other movement disorders in the health
care system.
''(d)(1) The Under Secretary for Health shall establish a panel to
assess the scientific and clinical merit of proposals that are
submitted to the Secretary for the establishment of new centers under
this section.
''(2)(A) The membership of the panel shall consist of experts in
neurodegenerative diseases, including Parkinson's Disease, and other
movement disorders.
''(B) Members of the panel shall serve as consultants to the
Department for a period of no longer than two years except in the case
of panelists asked to serve on the initial panel as specified in
subparagraph (C).
''(C) In order to ensure panel continuity, half of the members of
the first panel shall be appointed for a period of three years and half
for a period of two years.
''(3) The panel shall review each proposal submitted to the panel
by the Under Secretary and shall submit its views on the relative
scientific and clinical merit of each such proposal to the Under
Secretary.
''(4) The panel shall not be subject to the Federal Advisory
Committee Act.
''(e) Before providing funds for the operation of any such center
at a health-care facility other than a health-care facility designated
under subsection (b)(1), the Secretary shall assure that the center at
each facility designated under such subsection is receiving adequate
funding to enable such center to function effectively in the areas of
Parkinson's Disease research, education, and clinical activities.
''(f) There are authorized to be appropriated such sums as may be
necessary for the support of the research and education activities of
the centers established pursuant to subsection (a). The Under Secretary
for Health shall allocate to such centers from other funds appropriated
generally for the Department medical services account and medical and
prosthetics research account, as appropriate, such amounts as the Under
Secretary for Health determines appropriate.
''(g) Activities of clinical and scientific investigation at each
center established under subsection (a) shall be eligible to compete
for the award of funding from funds appropriated for the Department
medical and prosthetics research account and shall receive priority in
the award of funding from such account insofar as funds are awarded to
projects for research in Parkinson's disease and other movement
disorders.''.
(2) Clerical amendment.--The table of sections at the
beginning of such chapter is amended by inserting after the
item relating to section 7328 the following new item:

''7329. Parkinson's disease research, education, and clinical
centers.''.
(b) Effective Date.--Section 7329 of title 38, United States Code,
as added by subsection (a), shall take effect on October 1, 2005.
Output:
Directs the Secretary of Veterans to designate, establish, and operate at selected Department of Veterans Affairs health-care facilities six centers for Parkinson's disease research, education, and clinical activities. Requires the Under Secretary for Health to establish a panel to assess the scientific and clinical merit of proposals submitted by a facility for the operation of such a center.